An enhanced-affinity trifluorinated glucocorticoid, with potent anti-inflammatory activity and low systemic exposure.
Allergic Rhinitis is a common atopic Condition of the Nasal Mucosa Affecting 10-30% Population
Shows high concentrations of the drug with rapid onset of action.
Provides excellent topical potency & low potential for systemic effects.
Inhibits pro-inflammatory transcription factors and antigen-induced lung eosinophilia.
Produces high receptor affinity as compare to mometasone furcate and fluficasons propionate.
RECOMMENDED DOSAGE
27.5 micrograms per spray actuation in each nostril once a day.
Become a PCD Pharma Franchise Owner
Start your own PCD Pharma Franchise in your region by becoming a partner with a Trusted PCD Pharma Franchise Partner. Apply now and our expert team will reach out to you!
[wpforms id=”3367″]
After downloading this form you will receive our product list.